Rhythm Pharmaceuticals Inc (RYTM)

58.76 -1.25 (-2.08%) USD  |  NASDAQ  |  Jan 08, 13:11
More

Rhythm Pharmaceuticals Research and Development Expense (Annual): 134.95M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
MannKind Corp 31.28M
TG Therapeutics Inc 76.19M
Voyager Therapeutics Inc 92.17M
Krystal Biotech Inc 46.43M
NovaBay Pharmaceuticals Inc 0.068M